FdaApplication

NDA 209022

Back to search

Identifiers

Properties

PropertyValue
applicant_namePARATEK PHARMACEUTICALS INC
application_typeNDA
approval_date2017-09-18

Products (1)

ProductActive ingredientStrengthDosage form
XHANCEFLUTICASONE PROPIONATE0.093MG/SPRAYSPRAY, METERED;NASAL

1 product